Press Release | Association for Accessible Medicines

May 30, 2024 | Brian Hart

AAM Submits Comments to HHS and FTC on the Impact of GPOs and Wholesalers on Access to Generic Medicines

May 21, 2024 | Brian Hart

AAM Applauds Senate Judiciary Committee Efforts to Protect Patients and Skinny Labeling

Senior getting medicines at pharmacy counter

Apr 17, 2024 | Brian Hart

Seniors Pay More for Generic Medicines Every Year While Prices Continue to Fall. Why?

Medicare Pharmacy Avalere Analysis

Feb 20, 2024 | Brian Hart

Medicare Plans Increase Patient Costs for Generic Medicines

Feb 14, 2024 | Brian Hart

AAM Commends HHS and FTC Call for Information and Solutions on Drug Shortages and Patient Access to Generics and Biosimilars

Hatch-Waxman Turns 40

Feb 5, 2024 | Brian Hart

AAM White Paper: Hatch-Waxman Turns 40

Jan 23, 2024 | Brian Hart

Keren Haruvi Named Chair of the Association for Accessible Medicines Board of Directors

Illinois State Capitol

Jan 23, 2024 | Brian Hart

AAM Requests Federal Injunction to Block Illinois’ Unconstitutional Drug Price Law

Dec 8, 2023 | Brian Hart

Keren Haruvi Announced as Chair of the Association for Accessible Medicines Board of Directors

Drug Shortages in the US 2023 A Closer Look at Volume and Price Dynamics

Nov 15, 2023 | Brian Hart

AAM Statement on IQVIA Institute Report Examining Drug Shortages

2023 The U.S. Generic & Biosimilar Medicines Savings Report

Sep 6, 2023 | Monét Stanford

Generic and Biosimilar Drugs Generate $408 Billion in Savings For America’s Patients and Health-Care System in 2022

Image of MN State House

Jul 5, 2023 | Susan Reilly

AAM Requests Federal Injunction to Block Minnesota’s Unconstitutional Drug Price Law